David A. Palm

Member, Community Advisory Board, North Carolina

University of North Carolina at Chapel Hill

David A. Palm

Share this page

2012 – present Committee member, AIDS Clinical Trials Unit CAB, University of North Carolina at Chapel Hill 2013 – present CAB member, Collaboratory for AIDS Researchers for Eradication (CARE), Martin Delaney Collaboratory, NIH 2013 – present Board member, AIDS Treatment Activists Coalition (ATAC) 2011 – present Committee member, Immune Activation Focus Group, End-Organ Disease and Inflammation Translational Science Group (“ITSG”), ACTG 2011 – present Committee member, Reservoir Sampling Focus Group, HIV Reservoirs and Viral Eradication Translational Science Group, ACTG 2013 – 2014 Committee member, Gene Therapy Working Group, HIV Reservoirs and Viral Eradication Translational Science Group 2012 – 2013 Committee member, Scientific Agenda Steering Committee (SASC), ACTG 2012 – 2013 Committee member, Executive Committee (AEC), ACTG 2011 – 2012 Committee member, HIV Reservoirs and Viral Eradication Translational Science Group (“Cure TSG”), ACTG 2010 – 2012 Committee member, Neurology Core, ACTG 2010 – 2013 Non-scientist member, Clinical Core Internal Advisory Board, Duke University Center for AIDS Research 2009 – 2013 GCAB Community Scientific Subcommittee (CSS) member, ACTG 2009 – 2011 Committee member, Translational Research and Drug Development (TRADD), ACTG 2008 – 2013 Member, Global Community Advisory Board (GCAB), AIDS Clinical Trials Group (ACTG), DAIDS/NIAID/NIH